Tina Susan Nova
Director · Aurinia Pharmaceuticals Inc.
Individual
- 2025
- Jun 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Tina Susan Nova files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Tang - $25.14M in AUPH purchases and sales in the last 12 months
- Stephen P. Robertson - $546K in AUPH purchases and sales in the last 12 months
- John Aballi - $474K in XGN purchases and sales in the last 12 months
- William L. Cornog - $354K in AZTA purchases and sales in the last 12 months
- Alan J. Malus - $320K in AZTA purchases and sales in the last 12 months
- Jeffrey G. Black - $154K in XGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Tina Susan Nova?
Tina Susan Nova is a corporate insider, tracked as Director of Aurinia Pharmaceuticals Inc. (AUPH). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Tina Susan Nova last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 4 filings going back to 2025.
